RNA Targeting Small Molecules Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on rna targeting small molecules therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for rna targeting small molecules therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rna targeting small molecules therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators; RNA (Ribonucleic Acid) Splicing Modification; Direct RNA (Ribonucleic Acid) Targeting; Other Offerings
2) By Therapeutic Indication: Lung Fibrosis; Cancer; Neurodegenerative Diseases; Autoimmune; Inflammatory; Other Therapeutic Indications
3) By Application: Drug Discovery; Oncology Research; Disease Identification
4) By End User: Hospitals; Research Laboratories; Pharmaceutical And Biotechnology Companies; Other End-Users
Subsegments:
1) By mRNA (Messenger Ribonucleic Acid) Translation Modulators: Small Molecule Inhibitors; Enhancers Of Translation
2) By RNA (Ribonucleic Acid) Splicing Modification: Splicing Modulators; Antisense Oligonucleotides
3) By Direct RNA (Ribonucleic Acid) Targeting: RNA-Binding Small Molecules; RNA Aptamers
4) By Other Offerings: RNA Interference (RNAi) Therapeutics; Small Molecule Activators Of RNA Stability
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Bayer AG; Sanofi S.A.; AstraZeneca plc; Eli Lilly and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
- 1. Executive Summary
- 2. RNA Targeting Small Molecules Therapeutics Market Characteristics
- 3. RNA Targeting Small Molecules Therapeutics Market Trends And Strategies
- 4. RNA Targeting Small Molecules Therapeutics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
- 5. Global RNA Targeting Small Molecules Therapeutics Growth Analysis And Strategic Analysis Framework
- 5.1. Global RNA Targeting Small Molecules Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global RNA Targeting Small Molecules Therapeutics Market Growth Rate Analysis
- 5.4. Global RNA Targeting Small Molecules Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global RNA Targeting Small Molecules Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global RNA Targeting Small Molecules Therapeutics Total Addressable Market (TAM)
- 6. RNA Targeting Small Molecules Therapeutics Market Segmentation
- 6.1. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- mRNA (Messenger Ribonucleic Acid) Translation Modulators
- RNA (Ribonucleic Acid) Splicing Modification
- Direct RNA (Ribonucleic Acid) Targeting
- Other Offerings
- 6.2. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Lung Fibrosis
- Cancer
- Neurodegenerative Diseases
- Autoimmune
- Inflammatory
- Other Therapeutic Indications
- 6.3. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug Discovery
- Oncology Research
- Disease Identification
- 6.4. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Research Laboratories
- Pharmaceutical And Biotechnology Companies
- Other End-Users
- 6.5. Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of mRNA (Messenger Ribonucleic Acid) Translation Modulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Small Molecule Inhibitors
- Enhancers Of Translation
- 6.6. Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of RNA (Ribonucleic Acid) Splicing Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Splicing Modulators
- Antisense Oligonucleotides
- 6.7. Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of Direct RNA (Ribonucleic Acid) Targeting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- RNA-Binding Small Molecules
- RNA Aptamers
- 6.8. Global RNA Targeting Small Molecules Therapeutics Market, Sub-Segmentation Of Other Offerings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- RNA Interference (RNAi) Therapeutics
- Small Molecule Activators Of RNA Stability
- 7. RNA Targeting Small Molecules Therapeutics Market Regional And Country Analysis
- 7.1. Global RNA Targeting Small Molecules Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global RNA Targeting Small Molecules Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market
- 8.1. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China RNA Targeting Small Molecules Therapeutics Market
- 9.1. China RNA Targeting Small Molecules Therapeutics Market Overview
- 9.2. China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India RNA Targeting Small Molecules Therapeutics Market
- 10.1. India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan RNA Targeting Small Molecules Therapeutics Market
- 11.1. Japan RNA Targeting Small Molecules Therapeutics Market Overview
- 11.2. Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia RNA Targeting Small Molecules Therapeutics Market
- 12.1. Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia RNA Targeting Small Molecules Therapeutics Market
- 13.1. Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea RNA Targeting Small Molecules Therapeutics Market
- 14.1. South Korea RNA Targeting Small Molecules Therapeutics Market Overview
- 14.2. South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe RNA Targeting Small Molecules Therapeutics Market
- 15.1. Western Europe RNA Targeting Small Molecules Therapeutics Market Overview
- 15.2. Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK RNA Targeting Small Molecules Therapeutics Market
- 16.1. UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany RNA Targeting Small Molecules Therapeutics Market
- 17.1. Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France RNA Targeting Small Molecules Therapeutics Market
- 18.1. France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy RNA Targeting Small Molecules Therapeutics Market
- 19.1. Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain RNA Targeting Small Molecules Therapeutics Market
- 20.1. Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe RNA Targeting Small Molecules Therapeutics Market
- 21.1. Eastern Europe RNA Targeting Small Molecules Therapeutics Market Overview
- 21.2. Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia RNA Targeting Small Molecules Therapeutics Market
- 22.1. Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America RNA Targeting Small Molecules Therapeutics Market
- 23.1. North America RNA Targeting Small Molecules Therapeutics Market Overview
- 23.2. North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA RNA Targeting Small Molecules Therapeutics Market
- 24.1. USA RNA Targeting Small Molecules Therapeutics Market Overview
- 24.2. USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada RNA Targeting Small Molecules Therapeutics Market
- 25.1. Canada RNA Targeting Small Molecules Therapeutics Market Overview
- 25.2. Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America RNA Targeting Small Molecules Therapeutics Market
- 26.1. South America RNA Targeting Small Molecules Therapeutics Market Overview
- 26.2. South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil RNA Targeting Small Molecules Therapeutics Market
- 27.1. Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East RNA Targeting Small Molecules Therapeutics Market
- 28.1. Middle East RNA Targeting Small Molecules Therapeutics Market Overview
- 28.2. Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa RNA Targeting Small Molecules Therapeutics Market
- 29.1. Africa RNA Targeting Small Molecules Therapeutics Market Overview
- 29.2. Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. RNA Targeting Small Molecules Therapeutics Market Competitive Landscape And Company Profiles
- 30.1. RNA Targeting Small Molecules Therapeutics Market Competitive Landscape
- 30.2. RNA Targeting Small Molecules Therapeutics Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 31. RNA Targeting Small Molecules Therapeutics Market Other Major And Innovative Companies
- 31.1. Amgen Inc.
- 31.2. Janssen Pharmaceuticals
- 31.3. Vertex Pharmaceuticals
- 31.4. Servier laboratories
- 31.5. Genentech Inc.
- 31.6. PTC Therapeutics Inc.
- 31.7. Arrakis Therapeutics
- 31.8. Anima Biotech Inc.
- 31.9. Skyhawk Therapeutics Inc.
- 31.10. Remix Therapeutics
- 31.11. Abivax SA
- 31.12. 858 Therapeutics
- 31.13. Eloxx Pharmaceuticals Inc.
- 31.14. STORM Therapeutics Ltd.
- 31.15. Accent Therapeutics Inc.
- 32. Global RNA Targeting Small Molecules Therapeutics Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The RNA Targeting Small Molecules Therapeutics Market
- 34. Recent Developments In The RNA Targeting Small Molecules Therapeutics Market
- 35. RNA Targeting Small Molecules Therapeutics Market High Potential Countries, Segments and Strategies
- 35.1 RNA Targeting Small Molecules Therapeutics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 RNA Targeting Small Molecules Therapeutics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 RNA Targeting Small Molecules Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook